Education
About Us
Working with TipRanks
Follow Us
Syngene International Ltd. (IN:SYNGENE)
:SYNGENE
SYNGENE Stock Chart & Stats
₹648.85
-₹6.75(-0.77%)
At close: 4:00 PM EST
₹648.85
-₹6.75(-0.77%)
Day’s Range― - ―
52-Week Range₹598.55 - ₹960.00
Previous CloseN/A
Volume273.46K
Average Volume (3M)59.93K
Market Cap
₹260.38B
Enterprise Value₹251.73B
Total Cash (Recent Filing)₹11.63B
Total Debt (Recent Filing)₹5.74B
Price to Earnings (P/E)51.1
Beta0.76
Next Earnings
Jan 22, 2026EPS Estimate
2.57Last Dividend Ex-Date
Jun 27, 2025Dividend Yield0.19%
Share Statistics
EPS (TTM)1.80
Shares Outstanding402,939,420
10 Day Avg. Volume148,500
30 Day Avg. Volume59,929
Financial Highlights & Ratios
PEG Ratio-20.51
Price to Book (P/B)6.10
Price to Sales (P/S)7.91
P/FCF Ratio72.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Syngene International Ltd. News
SYNGENE FAQ
What was Syngene International Ltd.’s price range in the past 12 months?
Syngene International Ltd. lowest stock price was ₹598.55 and its highest was ₹960.00 in the past 12 months.
What is Syngene International Ltd.’s market cap?
Syngene International Ltd.’s market cap is ₹260.38B.
When is Syngene International Ltd.’s upcoming earnings report date?
Syngene International Ltd.’s upcoming earnings report date is Jan 22, 2026 which is in 51 days.
How were Syngene International Ltd.’s earnings last quarter?
Syngene International Ltd. released its earnings results on Nov 05, 2025. The company reported ₹1.8 earnings per share for the quarter, missing the consensus estimate of ₹2.167 by -₹0.367.
Is Syngene International Ltd. overvalued?
According to Wall Street analysts Syngene International Ltd.’s price is currently Overvalued.
Does Syngene International Ltd. pay dividends?
Syngene International Ltd. pays a Annually dividend of ₹1.25 which represents an annual dividend yield of 0.19%. See more information on Syngene International Ltd. dividends here
What is Syngene International Ltd.’s EPS estimate?
Syngene International Ltd.’s EPS estimate is 2.57.
How many shares outstanding does Syngene International Ltd. have?
Syngene International Ltd. has 402,939,420 shares outstanding.
What happened to Syngene International Ltd.’s price movement after its last earnings report?
Syngene International Ltd. reported an EPS of ₹1.8 in its last earnings report, missing expectations of ₹2.167. Following the earnings report the stock price went up 0.503%.
Which hedge fund is a major shareholder of Syngene International Ltd.?
Currently, no hedge funds are holding shares in IN:SYNGENE
Company Description
Syngene International Ltd.
Syngene International Ltd. is a leading global contract research and manufacturing organization (CRMO) based in India. The company provides integrated services in drug discovery, development, and manufacturing to pharmaceutical, biotechnology, and agrochemical companies. Syngene operates across various sectors including biopharma, consumer goods, and animal health, offering a broad range of services such as chemistry, biology, and bioanalytical testing, as well as clinical development and regulatory support.
Technical Analysis
Aster DM Healthcare Ltd.
―
Biocon Limited
―
Gland Pharma Ltd.
―
Glenmark Pharmaceuticals Limited
―
Laurus Labs Ltd.
―